email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2956 - 2970
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Panacea Ventures Files to Raise $150 Million for China Healthcare
$5.00
Available
New World Development Invests in New Century Healthcare; Plans More China Clinics/Hospitals
$5.00
Available
Frontage Labs, a US-China CRO, Acquires Concord Biosciences
$5.00
Available
US-China Trade War May Affect Life Science Products
$5.00
Available
Denovo Starts US-China Phase III Study of Leukemia Treatment
$5.00
Available
Concord Medical Announces $238 Million Investment from CCIC
$5.00
Available
Terns Acquires Three Lilly Candidates; Raises $30 Million from Lilly Asia Ventures
$5.00
Available
China Moves to Encourage Higher Quality China-made Generic Drugs
$5.00
Available
Fosun Pharma Stays Committed to Expanding through R&D and M&A
$5.00
Available
CMAB Biopharma of Suzhou Announces $34 Million Series B
$5.00
Available
GDCC Acquires China Rights to Anti-Seizure Drug from Biscayne Neuro
$5.00
Available
Guangzhou MaxiNovel Awarded US Orphan Drug Status for AML Treatment
$5.00
Available
Ascentage Chooses Hong Kong Exchange for its IPO
$5.00
Available
Roivant Enters $95 Million Deal for China Rights to Novel Antibiotic
$5.00
Available
WuXi AppTec Approved for $910 Million Shanghai IPO
$5.00
Available